PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.18%
Net income growth under 50% of MCHP's 260.88%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.26%
Some D&A expansion while MCHP is negative at -0.06%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1028.57%
Negative yoy deferred tax while MCHP stands at 77.18%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-58.21%
Negative yoy working capital usage while MCHP is 143.99%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
104.24%
Inventory growth well above MCHP's 35.75%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-317.65%
Negative yoy usage while MCHP is 190.35%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
440.00%
Some yoy increase while MCHP is negative at -87.47%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.92%
Operating cash flow growth 1.25-1.5x MCHP's 30.95%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-43.83%
Both yoy lines negative, with MCHP at -23.43%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-11.34%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.22%
Liquidation growth of 12.22% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-76.52%
We reduce yoy invests while MCHP stands at 89.57%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-63.83%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
1.64%
Buyback growth of 1.64% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.